Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison McGeer

Showing results (191-200 of 434) with videos related to

Pageof 44
Sort By:
FEMS Microbiology Letters|March 1, 2007
ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolatesDobryan M Tracz, David A Boyd, Romeo Hizon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2014
Reducing antimicrobial therapy for asymptomatic bacteriuria among noncatheterized inpatients: a proof-of-concept studyJerome A Leis, Gabriel W Rebick, Nick Daneman, et al.
Antimicrobial Resistance and Infection Control|January 11, 2014
Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemicGeoffrey Taylor, Robyn Mitchell, Rachel Fernandes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 25, 2016
Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled TrialSusy S Hota, Valerie Sales, George Tomlinson, et al.
Journal of Clinical Microbiology|February 14, 2014
Outbreak of vancomycin-susceptible Enterococcus faecium containing the wild-type vanA geneTom A Szakacs, Lindsay Kalan, Michael J McConnell, et al.
Canadian Journal of Microbiology|July 26, 2012
Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010Walter H B Demczuk, Irene Martin, Averil Griffith, et al.
Emerging Infectious Diseases|March 27, 2015
Population structure and antimicrobial resistance of invasive serotype IV group B Streptococcus, Toronto, Ontario, CanadaSarah Teatero, Allison McGeer, Aimin Li, et al.
Antimicrobial Agents and Chemotherapy|December 2, 2009
Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006Heather J Adam, Lisa Louie, Christine Watt, et al.
Transfusion|December 21, 2019
A suspected septic transfusion reaction associated with posttransfusion contamination of a platelet pool by vancomycin-resistant Enterococcus faeciumSteven J Drews, Peter Lesley, Michael E Detsky, et al.
Infection Control and Hospital Epidemiology|February 13, 2010
Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: National Surveillance and Changing Epidemiology, 1995-2007Andrew E Simor, Nicolas L Gilbert, Denise Gravel, et al.
Pageof 44

Showing results (191-200 of 434) with videos related to

Sort By:
Pageof 44
FEMS Microbiology Letters|March 1, 2007
ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolatesDobryan M Tracz, David A Boyd, Romeo Hizon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2014
Reducing antimicrobial therapy for asymptomatic bacteriuria among noncatheterized inpatients: a proof-of-concept studyJerome A Leis, Gabriel W Rebick, Nick Daneman, et al.
Antimicrobial Resistance and Infection Control|January 11, 2014
Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemicGeoffrey Taylor, Robyn Mitchell, Rachel Fernandes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 25, 2016
Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled TrialSusy S Hota, Valerie Sales, George Tomlinson, et al.
Journal of Clinical Microbiology|February 14, 2014
Outbreak of vancomycin-susceptible Enterococcus faecium containing the wild-type vanA geneTom A Szakacs, Lindsay Kalan, Michael J McConnell, et al.
Canadian Journal of Microbiology|July 26, 2012
Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010Walter H B Demczuk, Irene Martin, Averil Griffith, et al.
Emerging Infectious Diseases|March 27, 2015
Population structure and antimicrobial resistance of invasive serotype IV group B Streptococcus, Toronto, Ontario, CanadaSarah Teatero, Allison McGeer, Aimin Li, et al.
Antimicrobial Agents and Chemotherapy|December 2, 2009
Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006Heather J Adam, Lisa Louie, Christine Watt, et al.
Transfusion|December 21, 2019
A suspected septic transfusion reaction associated with posttransfusion contamination of a platelet pool by vancomycin-resistant Enterococcus faeciumSteven J Drews, Peter Lesley, Michael E Detsky, et al.
Infection Control and Hospital Epidemiology|February 13, 2010
Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: National Surveillance and Changing Epidemiology, 1995-2007Andrew E Simor, Nicolas L Gilbert, Denise Gravel, et al.
Pageof 44